In CRC, NOS2 expression correlates with favorable prognosis and enhanced CD8+/CD4+ T cell infiltration, with NOS2 being essential for the efficacy of adoptive CD8+ T cell therapy (280). This evidence concerns the gene NOS2 and colorectal carcinoma.